Skip to main content

Table 2 Prevalence of metabolic syndrome (95%CI) and its components according to age and sex strata

From: Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study

Age groups

Abdominal obesity

Elevated blood pressure

Elevated blood glucose

Elevated triglycerides

Low HDL cholesterol

Metabolic syndrome

IDF

NCEP-ATP III

Total

 18-29 years

25.3(24.1-26.5)

12.0 (11.2-12.9)

25.0(23.8-26.2)

22.0(20.85-23.11)

75.7 (74.5-76.9)

13.4(12.4-14.3)

19.6(18.5-20.7)

 30-39 years

51.4(49.5-53.3)

24.7(23.0-26.3)

34.6(32.7-36.4)

38.83(37.0-40.7)

80.2(78.6-81.7)

33.8(31.96-35.6)

42.7(40.8-44.6)

 40-49 years

66.3(64.3-68.3)

38.6(36.5-40.6)

46.8(44.7-48.8)

41.55(39.5-43.6)

81.4(79.8-83.0)

49.4(47.3-51.5)

57.9(55.8-59.9)

 50-59 years

70.4(67.7-73.2)

53.31(50.3-56.3)

56.5(53.6-59.5)

42.4(39.4-45.3)

82.2(79.96-84.5)

56.3(53.3-49.2)

66.8(64.0-69.6)

 60-69 years

69.8(66.1-73.5)

63.4(59.4-67.3)

59.9(55.9-63.9)

44.0(39.9-48.0)

79.8(76.5-83.1)

58.5(54.4-62.5)

71.0(67.3-74.7)

  ≥ 70 years

59.7(54.9-64.4)

66.8(62.2-71.4)

57.7(52.9-62.5)

38.4(33.6-43.1)

78.7(74.7-82.7)

50.7 (45.9-55.6)

65.8(61.2-70.5)

Men

 18-29 years

27.7(25.9-29.5)

16.5(15.0-18.0)

28.4(26.6-30.3)

28.4(26.6-30.2)

71.0(69.2-72.9)

16.4(14.9-17.9)

24.4(22.7-26.2)

 30-39 years

52.4(49.6-55.1)

30.4 (27.9-32.9)

41.4(38.7-44.1)

49.61(49.9-52.4)

77.6(75.3-79.9)

39.26(36.7-41.94)

51.7(49.0-54.5)

 40-49 years

63.1(60.0-66.1)

41.2(38.1-44.3)

49.2(46.0-52.3)

51.1(47.9-54.3)

77.3(74.6-80.0)

49.5(46.3-52.7)

60.3(57.2-63.4)

 50-59 years

68.9(64.9-72.9)

58.2(54.0-62.4)

57.4(53.2-61.7)

49.6(45.3-53.9)

79.8(76.3-83.2)

57.25(53.0-61.5)

70.8(66.9-74.7)

 60-69 years

69.2(64.1-74.3)

61.9(56.5-67.3)

58.7(53.3-64.2)

47.0(41.5-52.5)

75.2(70.5-80.0)

58.7(53.3-64.2)

71.11(66.1-76.1)

  ≥ 70 years

55.9(48.8-63.1)

66.7(59.9-73.4)

59.7(52.6-66.7)

43.0(35.9-50.1)

69.4(62.7-76.0)

45.2(38.0-52.3)

61.8(54.9-68.8)

Women

 18-29 years

23.3(21.7-24.8)

8.40(7.38-9.42)

22.18(20.7-23.7)

16.77(15.4-18.1)

79.53(78.1-81.0)

10.9(9.8-12.1)

15.7(14.3-17.0)

 30-39 years

50.5(47.9-53.1)

19.4(17.3-21.4)

28.3(25.9-30.6)

28.9(26.5-31.3)

82.5(80.5-84.5)

28.7(26.3-31.5

34.3(31.8-36.8)

 40-49 years

68.7(66.1-71.3)

36.6(34.0-39.3)

45.0(42.2-47.7)

34.5(31.9-37.1)

84.5(82.5-86.5)

49.3(46.6-52.1)

56.1(53.3-58.8)

 50-59 years

71.9(68.2-75.6)

48.8(44.6-52.9)

55.7(51.6-58.8)

35.6(31.6-39.6)

84.5(81.5-87.5)

55.3(51.2-59.5)

63.0(59.0-67.0)

 60-69 years

70.5(65.0-76.1)

65.1(59.3-70.9)

61.2(55.3-67.2)

40.3(34.3-46.3)

85.3(81.0-89.6)

58.1(52.1-64.2)

70.9(65.4-76.5)

  ≥ 70 years

62.8(56.4-69.3)

67.0(60.7-73.2)

56.0(49.4-62.6)

34.4(28.1-40.7)

86.7(82.2-91.2)

55.5(48.9-62.1)

69.27(63.15-75.39)

  1. NCEP-ATP-III;, National Cholesterol Education Program and Adult Treatment Panel III, HDL; high density lipoprotein, IDF; International Diabetes Federation, LDL; low density lipoprotein